Taiwan FDA registration 952a18c000f178bf320978325785c2a6
Pharmigene B27 Detection Kit
TW: 世基B27檢測套組
Taiwan·Risk Class 2·MD·Shiji Biomedical Co., Ltd. Taipei Plant·Registered Oct 03, 2013 – Oct 03, 2028ActiveRegistration details
- Analysis ID
- 952a18c000f178bf320978325785c2a6
- License Form
- Ministry of Health Medical Device Manufacturing No. 004169
Company information
- Manufacturer
- Shiji Biomedical Co., Ltd. Taipei Plant
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PHARMIGENE, INC.
Product details
- Intended Use
- This product is a qualitative detection of HLA-B*27 gene by real-time polymerization and chain reaction technology.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B0001 Human leukocyte antigen segmentation board
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Oct 03, 2013
- Expiry Date
- Oct 03, 2028
About this record
Access comprehensive regulatory information for Pharmigene B27 Detection Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 952a18c000f178bf320978325785c2a6 and manufactured by Shiji Biomedical Co., Ltd. Taipei Plant. The authorized representative in Taiwan is PHARMIGENE, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices